Towards understanding aromatase inhibitory activity via QSAR modeling

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Biochemistry

Background:

• Aromatase is crucial for estrogen biosynthesis and is overexpressed in breast cancer.
• Aromatase inhibitors (AIs) are used to treat hormone-receptor positive breast cancer by reducing estrogen.
• Current synthetic AIs have side effects, driving the need for novel inhibitors.

Purpose of the Study:

• To provide the first comprehensive review of all published quantitative structure-activity relationship (QSAR) studies on aromatase inhibitors (AIs).
• To summarize the methodologies and key structural features identified in QSAR studies for both steroidal and non-steroidal AIs.
• To guide the development of new, effective aromatase inhibitors with potentially reduced side effects.

Main Methods:

• Systematic literature search for QSAR studies on steroidal and non-steroidal aromatase inhibitors.
• Analysis of experimental setups and data used in the reviewed QSAR studies.
• Identification and summarization of key molecular descriptors and structural features correlated with aromatase inhibition.

Main Results:

• Compilation of a comprehensive overview of QSAR studies in the field of aromatase inhibition.
• Identification of common structural motifs and physicochemical properties associated with potent AI activity.
• Summary of the predictive models and their validation strategies.

Conclusions:

• QSAR studies are valuable tools for understanding the mechanistic basis of aromatase inhibition.
• This review consolidates knowledge to facilitate the rational design of novel aromatase inhibitors.
• Further QSAR research can aid in developing safer and more effective breast cancer therapies.